We have been in the business of eClinical technology since 2005. Our goal has always been to make the world healthier through clinical trial technology, and combating diseases like COVID-19 is what we were made for. Not sure where to begin? Check out our Pandemic Guide to get started. We have plenty of resources, and we’re always here to help.
We have all been impacted by COVID-19, and with the novel virus comes novel challenges. You’ve had to rearrange workflows, find ways to assess your patients in their homes due to lockdown measures, and uphold patient safety standards, all while remaining compliant. As a result, you need technology that addresses these new challenges. Luckily, we’ve been supporting trials of any type—virtual, in-person, and hybrid—for years. We are here to help you work through any challenge and are committed to advancing clinical trial research (even during a global pandemic).
We’ve been watching and listening to see how the industry would react, revise, and re-engage. All signs point towards decentralization as a proven solution. To be fair, decentralized trials produce higher quality data and increase patient compliance. We know that for some, moving to a decentralized clinical model can be daunting. That’s why we’re here to help. We’re more than just our technical solutions—our experts are available to walk you through the process and offer guidance along the way.
Remember when we said we’ve been doing this for years? Here’s a webinar from 2018 where we discussed the rise of decentralized clinical trials with Bola Oyegunwa, Vice President and Global Head of Hybrid and Virtual Trials at Covance. We think a lot of this webinar still rings true.
Technology now allows people to connect anytime, anywhere, to anyone in the world, from almost any device. This is dramatically changing the way people work.